Nama: dr. Cita Herawati Murjantyo,SpTHT-KL Tempat/tgl lahir: Yogyakarta, 15 Maret Pekerjaan/ jabatan: Kepala Divisi Onkologi THT RS. Kanker Dharmais Bagian THT-RSI.Bintaro Riwayat pendidikan formal: Spesialis THT, FKUI RSCM-1998 Sedang pendidikan S3, Universitas Gajah Mada Yogyakarta Riwayat pendidikan Tambahan: Endoscopic and Skull Base Surgery, Masterclass, Milano 2003 OSAS Obstructive Sleep Apnea Syndrome/ SNORING, Singapore General Hospital, 2006 Head & Neck Course, Singapore General Hospital, 2007 European Allergic Course, Greece, 2008 European Academy of Allergy and Clinical Immunology Congress, Geneva, 2012 Instructional Course Skull Base Surgery, Jakarta, 2013
29
Embed
Nama: dr. Cita Herawati Murjantyo,SpTHT-KL · Nama: dr. Cita Herawati Murjantyo,SpTHT-KL Tempat/tgl lahir: Yogyakarta, 15 Maret Pekerjaan/ jabatan: Kepala Divisi Onkologi THT RS.
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Nama: dr. Cita Herawati Murjantyo,SpTHT-KL
Tempat/tgl lahir: Yogyakarta, 15 Maret
Pekerjaan/ jabatan:
Kepala Divisi Onkologi THT RS. Kanker Dharmais
Bagian THT-RSI.Bintaro
Riwayat pendidikan formal:
Spesialis THT, FKUI RSCM-1998
Sedang pendidikan S3, Universitas Gajah Mada Yogyakarta
Riwayat pendidikan Tambahan:
Endoscopic and Skull Base Surgery, Masterclass, Milano 2003
OSAS Obstructive Sleep Apnea Syndrome/ SNORING, Singapore General
Hospital, 2006
Head & Neck Course, Singapore General Hospital, 2007
European Allergic Course, Greece, 2008
European Academy of Allergy and Clinical Immunology Congress, Geneva,
2012
Instructional Course Skull Base Surgery, Jakarta, 2013
dr. Cita Herawati,SpTHT
RSK Dharmais
Definition (ARIA):
Allergic rhinitis is a symptomatic disorder of the nose
induced after allergen exposure by an immunoglobulin E (IgE)-
mediated inflammation of the membranes lining the nose
Bousquet J, Allergy 2008: 63 (Suppl. 86): 8–160
ARIA: Allergic Rhinitis and its Impact on Asthma
Allergic rhinitis is characterized by chronic nasal inflammation • IgE-mediated nasal response to allergens results in Mast cell activation
Release of chemical mediators
Influx of inflammatory cells
Early and late phase components
Adcock I, Clin Exp All Rev 2002; 2: 85-8
The classification "seasonal" and "perennial" allergic rhinitis
has been changed to
"intermittent" and "persistent" allergic rhinitis
Allergic Rhinitis:
Classification and
Management
Guideline
INTERMITTENT
<4 days per week or
<4 weeks
PERSISTENT
>4 days per week and
>4 weeks
MILD
Normal sleep and
No impairment of daily
activities, sport, leisure and
Normal work and school and
No troublesome symptoms
MODERATE–SEVERE
One or more items
Abnormal sleep
Impairment of daily activities,
sport, leisure
Impaired work and school
Troublesome symptoms
In untreated patients
Bousquet J et al. J Allergy Clin Immunol 2001;108(Suppl 5):S147–336; ARIA: at a glance pocket reference 2007.
ARIA, Allergic Rhinitis and its Impact on Asthma
ARIA = Allergic Rhinitis and its Impact on Asthma.
Bousquet et al. J Allergy Clin Immunol. 2001;108 (5 suppl):S147.
Mild
intermittent
Moderate
severe
intermittent
Mild
persistent
Moderate
severe
persistent
Immunotherapy
Allergen and irritant avoidance
Intranasal decongestant (<10 days) or oral decongestant
Second-generation nonsedating H1 antihistamine
Leukotriene receptor antagonists
Local cromone
Intra-nasal steroid
ARIA
2008
Intranasal corticosteroids are the most effective drugs and it becomes the first choice for moderate-severe persistent
allergic rhinitis. 1
Treatment may prevent development of co-morbidities
such as asthma, sinusitis or otitis media2,3
1. Bousquet J et al. J Allergy Clin Immunol. 2001;108(Suppl 5):S147–S334 2.Settipane R. Allergy Asthma Proc 1999;20:209–213